Engagement Model
We work with private equity-backed platforms in mental health, addiction treatment, eating disorders, dual diagnosis, IOP/PHP, and adjacent outpatient services. These are typically platforms with one to three initial acquisitions seeking to build proprietary add-on pipelines — or newly formed platforms identifying their first acquisition target.
Engagements center on designing and operating deal origination infrastructure that produces founder-sourced, off-market opportunities aligned to the platform's clinical and operational thesis. The outcome is a consistent, defensible pipeline that compounds across hold periods.
Mission-driven nonprofit organizations pursuing affiliation strategies — combining with other nonprofits to expand geographic reach, service breadth, and operational resilience — require a different origination approach than PE platforms. Seller motivations, cultural compatibility, and mission alignment carry more weight than in for-profit transactions.
We design origination systems that identify and qualify affiliation candidates aligned on clinical philosophy, community mission, and operational compatibility. The goal is a pipeline of partners, not just targets.
Independent sponsors, family offices, and strategic operators raising or deploying their first behavioral health platform investment. These acquirers typically need to identify a platform acquisition, build a thesis, and demonstrate proprietary sourcing capability to capital partners — often before committing significant internal resources.
We provide the origination infrastructure that makes a pre-platform sponsor look like an established platform. The engagement produces a vetted pipeline and a repeatable process that LPs and co-investors can underwrite.
Process
Every engagement begins with discovery. We spend time understanding the acquirer's investment thesis, target criteria, existing pipeline, and what "good" looks like from a clinical, cultural, and operational standpoint. This is not a questionnaire — it's a working dialogue that surfaces constraints the acquirer may not have articulated internally.
From discovery, we move to target criteria refinement. Most acquirers arrive with a target profile that is either too narrow to produce sufficient flow or too broad to be actionable. We pressure-test the criteria against market realities — geography, service line, payer mix, facility type, revenue threshold, and owner psychology — and tighten until the profile is both specific and realistic.
Market mapping follows. We identify every behavioral health operator in the defined geography and sub-segment, build founder profiles, track ownership structures, and map referral relationships. This is not list-building. It is systematic intelligence gathering that reveals which targets are actionable, which are not, and why.
Outreach is direct, founder-to-founder, and conducted by someone who has done the clinical work and run the business development function inside a behavioral health organization. Founders speak differently to operators than they do to bankers. The difference in access and candor is material.
Qualification is where operator-led diligence matters most. Before any target is introduced to the acquirer, we screen for clinical fit, operational health, payer mix, regulatory posture, leadership culture, and quality indicators. Targets that pass financial screens but fail clinical or cultural screens are not introduced. We do not bring our clients targets we cannot defend.
The hand-off to internal corp dev is warm and structured. Every introduction includes a pre-qualification brief covering what we found, why it fits the thesis, and what questions the acquirer should ask. The origination infrastructure remains in place for the duration of the engagement, producing a steady flow of vetted opportunities — not a one-time list.
Boundaries
We are not investment bankers, business brokers, or M&A advisors. We do not represent sellers, manage deal processes, or take success fees tied to transaction close. Our work ends when a qualified target is introduced. Transaction execution belongs to the acquirer and their advisors.
We do not run digital advertising, SEO campaigns, content marketing, or lead generation programs. Origination infrastructure is not marketing — it is a systematic process of identifying, qualifying, and introducing specific, vetted targets to a specific acquirer.
We do not accept engagements where origination is separated from clinical and cultural diligence. A target that fits financially but fails on clinical quality, regulatory posture, or cultural alignment is not a target we will introduce — and an acquirer who does not want that screening is not a client we will take.
In a market reshaped by federal investigations into for-profit behavioral health operators, the targets we introduce carry reputational and regulatory risk for our clients. We do not introduce targets whose clinical practices, billing patterns, or leadership cultures would expose an acquirer to downstream liability or brand damage.